MassDevice.com +3 | The top 3 medtech stories for August 24, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. ‘Go-shop’ lapses without new rival for St. Jude’s $3B Thoratec buy
A 30-day “go-shop” period in St. Jude Medical’s pending, $3.4 billion acquisition of Thoratec lapsed without a 2nd suitor emerging, sending the companies’ stock prices down slightly.
The merger, medtech’s latest multi-billion union, calls for St. Jude to pay $63.50 in cash for each share of Pleasanton, Calif.-based Thoratec, funded using term loans and senior unsecured debt. Read more
2. TriVascular Technologies raises $10m, launches study of EVAR in women
Trivascular Technologies said it raised a $10 million funding round and launched a clinical study of endovascular aortic repair in women using its Ovation stent graft.
Santa Rosa, Calif.-based TriVascular said in a regulatory filing that it raised $10 million from 5 unnamed investors in a debt-and-warrants offering. The company, which won pre-market approval from the FDA this month for its Ovation iX device, raised $78 million in April 2014 with an initial public offering. Read more
1. Vital Therapies trial fails to meet endpoints
Vital Therapies said that the Phase...
Source: Mass Device - Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news
More News: Alcoholism | Clinical Trials | Endovascular Repair (EVAR) | Funding | Gastroschisis Repair | Health | Liver | Medical Devices | Mergers and Aquisitions | Study | Urology & Nephrology | Women